A Tale of Two Ends: Repurposing Metallic Compounds from Anti-Tumour Agents to Effective Antibacterial Activity

被引:5
|
作者
Ferreira, Daniela Alves [1 ]
Martins, Luisa M. D. R. S. [2 ,3 ]
Fernandes, Alexandra R. [4 ]
Martins, Marta [1 ]
机构
[1] Univ Dublin, Trinity Coll Dublin, Coll Green, Dept Microbiol,Sch Genet & Microbiol, Dublin D02 PN40 2, Ireland
[2] Univ Lisbon, Ctr Quim Estrutural, P-1049001 Lisbon, Portugal
[3] Univ Lisbon, Dept Engn Quim, Inst Super Tecn, P-1049001 Lisbon, Portugal
[4] UCIBIO, Dept Ciencias Vida, Fac Ciencias & Tecnol, Campus Caparica, P-2829516 Caparica, Portugal
来源
ANTIBIOTICS-BASEL | 2020年 / 9卷 / 06期
关键词
antimicrobial resistance; drug repurposing; metallic compounds; GRAM-NEGATIVE BACTERIA; MECHANISMS; RESISTANCE; FLAGELLAR; EFFICACY;
D O I
10.3390/antibiotics9060321
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The rise in antibiotic resistance coupled with the gap in the discovery of active molecules has driven the need for more effective antimicrobials while focusing the attention into the repurpose of already existing drugs. Here, we evaluated the potential antibacterial activity of one cobalt and two zinc metallic compounds previously reported as having anticancer properties. Compounds were tested against a range of Gram-positive and -negative bacteria. The determination of the minimum inhibitory and bactericidal concentrations (MIC/MBC) of the drugs were used to assess their potential antibacterial activity and their effect on bacterial growth. Motility assays were conducted by exposing the bacteria to sub-MIC of each of the compounds. The effect of sub-MIC of the compounds on the membrane permeability was measured by ethidium bromide (EtBr) accumulation assay. Cell viability assays were performed in human cells. Compound TS262 was the most active against the range of bacteria tested. No effect was observed on the motility or accumulation of EtBr for any of the bacteria tested. Cell viability assays demonstrated that the compounds showed a decrease in cell viability at the MIC. These results are promising, and further studies on these compounds can lead to the development of new effective antimicrobials.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 50 条
  • [1] Gold compounds in medicine: Potential anti-tumour agents
    Edward R. T. Tiekink
    Gold Bulletin, 2003, 36 (4) : 117 - 124
  • [2] Antioxidant and anti-tumour activity of triterpenoid compounds isolated from Morchella mycelium
    Wang Zhuo
    Wang Hongling
    Kang Zongli
    Wu You
    Xing Yao
    Yang Yuhong
    ARCHIVES OF MICROBIOLOGY, 2020, 202 (07) : 1677 - 1685
  • [3] Antioxidant and anti-tumour activity of triterpenoid compounds isolated from Morchella mycelium
    Zhuo Wang
    Hongling Wang
    Zongli Kang
    You Wu
    Yao Xing
    Yuhong Yang
    Archives of Microbiology, 2020, 202 : 1677 - 1685
  • [4] Antibacterial Peptide Physicochemical Properties of Pomacea Canaliculata and Anti-tumour Activity Determination
    Liu, Jiantao
    Li, Yuping
    Wang, Chenxi
    Chang, Jun
    2013 3RD INTERNATIONAL CONFERENCE ON SOCIAL SCIENCES AND SOCIETY (ICSSS 2013), PT 4, 2013, 35 : 191 - 196
  • [5] Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
    Nitzsche, B.
    Gloesenkamp, C.
    Schrader, M.
    Hoffmann, B.
    Zengerling, F.
    Balabanov, S.
    Honecker, F.
    Hoepfner, M.
    BRITISH JOURNAL OF CANCER, 2012, 107 (11) : 1853 - 1863
  • [6] Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
    B Nitzsche
    C Gloesenkamp
    M Schrader
    B Hoffmann
    F Zengerling
    S Balabanov
    F Honecker
    M Höpfner
    British Journal of Cancer, 2012, 107 : 1853 - 1863
  • [7] Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate
    Qiu, L
    Kelso, MJ
    Hansen, C
    West, ML
    Fairlie, DP
    Parsons, PG
    BRITISH JOURNAL OF CANCER, 1999, 80 (08) : 1252 - 1258
  • [8] Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate
    L Qiu
    M J Kelso
    C Hansen
    M L West
    D P Fairlie
    P G Parsons
    British Journal of Cancer, 1999, 80 : 1252 - 1258
  • [9] HIV protease inhibitors: antiretroviral agents with anti-inflammatory, anti-angiogenic and anti-tumour activity
    Monini, P
    Sgadari, C
    Barillari, G
    Ensoli, B
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (02) : 207 - 211
  • [10] Diarylheptanoid analogues from the rhizomes of Zingiber officinale and their anti-tumour activity
    Li, Ting
    Pan, Da-bo
    Pang, Qian-qian
    Zhou, Mi
    Yao, Xiao-jun
    Yao, Xin-sheng
    Li, Hai-bo
    Yu, Yang
    RSC ADVANCES, 2021, 11 (47) : 29376 - 29384